SENEXON-S is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Rugby Laboratories, Inc.. The primary component is Docusate Sodium; Sennosides A And B.
Product ID | 0536-4086_aaa2cb99-378e-74e8-e053-2a95a90aa2d6 |
NDC | 0536-4086 |
Product Type | Human Otc Drug |
Proprietary Name | SENEXON-S |
Generic Name | Docusate Sodium -sennosides |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-03-16 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | RUGBY LABORATORIES, INC. |
Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
Active Ingredient Strength | 50 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-07-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-03-16 |
Marketing End Date | 2018-01-01 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-03-16 |
Marketing End Date | 2018-01-01 |
Ingredient | Strength |
---|---|
DOCUSATE SODIUM | 50 mg/1 |
SPL SET ID: | bb2064aa-b820-4e07-962a-a506145942df |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0536-1247 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
0536-4086 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
0615-7773 | SENEXON-S | docusate sodium-sennosides tablet |
0615-8083 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
0615-8331 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
33261-749 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
52959-675 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
68788-9407 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
43063-818 | Docusate Sodium with Sennosides | DOCUSATE SODIUM -SENNOSIDES |